ERYTECH makes its 2016 Reference Document available Post author:admERY Post published:April 3, 2017 Post category:Newsroom ERYTECH today announced that it had filed on March 31, 2017 with the “Autorité des Marchés Financiers (AMF)”, its 2016 Reference Document, including the management report and the annual financial report. You Might Also Like ERYTECH Pharma receives FDA IND clearance to initiate a clinical study in Acute Lymphoblastic Leukemia in the U.S. April 3, 2013 ERYTECH Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy May 14, 2018 ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer April 28, 2020
ERYTECH Pharma receives FDA IND clearance to initiate a clinical study in Acute Lymphoblastic Leukemia in the U.S. April 3, 2013
ERYTECH Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy May 14, 2018
ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer April 28, 2020